<< Back to Results
Chronic Migraine Treatment Trial - The study is to compare the reduction at 6 months in the number of days with severe headache, with a baseline period measured while on topiramate, in participants with chronic migraine treated with topiramate and propranolol, versus those treated with topiramate and placebo.
- Principal Investigator(s)
- Brad Klein, M.D.
- David Weisman, M.D. (Sub-Investigator)
Clinical Trial Categories
- Jennifer McGowan at 215-327-0161
- Abington Neurological Associates, Ltd